共 30 条
[4]
Side Effects of Bacillus Calmette-Guerin (BCG) in the Treatment of Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG
[J].
EUROPEAN UROLOGY,
2014, 65 (01)
:69-76
[5]
Caravaca-Fontán F, 2016, NEFROLOGIA, V36, P711, DOI [10.1016/j.nefroe.2017.01.003, 10.1016/j.nefro.2016.06.001]
[6]
Hypersensitivity pneumonitis as a complication of intravesical BCG therapy for bladder cancer
[J].
ARCHIVOS DE BRONCONEUMOLOGIA,
2016, 52 (08)
:445-446
[9]
Diner Eric K., 2004, Int. braz j urol., V30, P400, DOI 10.1590/S1677-55382004000500008